IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,477 | +41.9% | 8,895 | +28.4% | 0.20% | +53.4% |
| Q2 2023 | $284,297 | -12.0% | 6,929 | -23.4% | 0.13% | -40.6% |
| Q1 2023 | $323,090 | -32.3% | 9,040 | -28.5% | 0.22% | -43.0% |
| Q4 2022 | $477,337 | +14.5% | 12,638 | +34.1% | 0.39% | -22.9% |
| Q3 2022 | $417,000 | +34.1% | 9,423 | +12.2% | 0.51% | +73.5% |
| Q2 2022 | $311,000 | -4.6% | 8,398 | -4.7% | 0.29% | +108.5% |
| Q1 2022 | $326,000 | – | 8,809 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |